Tech Company Inital Public Offerings

Biodel IPO

Biodel, operating out of Danbury, debuted as a public company on 2/7/2008.

Transaction Overview

Company Name
Announced On
2/7/2008
Transaction Type
IPO
Amount
$46,400,000
Proceeds Purpose

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
100 Saw Mill Rd.
Danbury, CT 06810
USA
Email Address
Overview
Biodel Inc. is a specialty pharmaceutical company that develops novel formulations of FDA approved therapeutics to treat endocrine disorders such as diabetes. Biodel's products are created by utilizing the company's proprietary VIAdel technology.
Profile
Biodel LinkedIn Company Profile
Social Media
Biodel Company Twitter Account
Company News
Biodel News
Facebook
Biodel on Facebook
YouTube
Biodel on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Solomon Steiner
  Solomon Steiner LinkedIn Profile  Solomon Steiner Twitter Account  Solomon Steiner News  Solomon Steiner on Facebook
Chief Financial Officer
Gerard Michel
  Gerard Michel LinkedIn Profile  Gerard Michel Twitter Account  Gerard Michel News  Gerard Michel on Facebook
Chief Medical Officer
Alan Krasner
  Alan Krasner LinkedIn Profile  Alan Krasner Twitter Account  Alan Krasner News  Alan Krasner on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/7/2008: SmartShoot venture capital transaction
Next: 2/7/2008: Cequent Pharmaceuticals venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We report on every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary